Verifying The Association Between IL6 -174G/C Polymorphism in Type 2 Diabetes Mellitus

المؤلفون

  • Nawfal. N. Al-azzawi College of Science, University of Baghdad , Baghdad, Iraq.
  • Maysoon. K. Hussein College of Science, University of Baghdad , Baghdad, Iraq.
  • Muna I. Khalaf College of Science, University of Baghdad , Baghdad, Iraq.

Background : Diabetes mellitus, also known as blood sugar, is a series of metabolic disorders described by high blood glucose levels (hyperglycemia), low blood glucose (hypoglycemia), or both, resulting from defects in insulin production, insulin action, or both. Numerous studies have shown that interleukin (IL-6) acts on skeletal muscle cells , liver cells, and pancreas cells to influence glucose balance and metabolism, which directly or indirectly contributes to the development of diabetes. Research in this area is crucial because diabetes is recognized as a major risk factor for many diseases like Diabetic retinopathy, Diabetic nephropathy, Diabetic Neuropathy , heart disease and others.  Patients and methods : In this study, we tested three of genotypes GG; GC ; CC for IL6 -174G/C polymorphism to determine its association with type 2 diabetes and its effect on insulin. One hundred T2DM patients and 100 clinically healthy participants were enrolled in the study.  Results and Conclusion : Based on the results presented by the researcher, the three genetic polymorphisms GG, GC, and CC of the IL6-174G/C polymorphism did not appear to be associated with type 2 diabetes or determine the course of the disease. Given society’s demand for radical solutions and the necessity of reducing the increasing number of deaths every year, these findings underscore the need for continued research into understanding the complex interplay of factors that contribute to diabetes-related complications.

الكلمات المفتاحية:

Diabetes، IL6 -174G/C polymorphism، PCR

[1] Amirian, A., Mahani, M. B., & Abdi, F. (2020). Role of interleukin-6 (IL-6) in predicting gestational diabetes mellitus. Obstetrics & Gynecology Science, 63(4), 407-416.‏

[2] Caughey, A. B., Werner, E. F., & Barss, V. A. (2022). Gestational diabetes mellitus: Obstetric issues and management. UpToDate (online).‏

[3] Roden, M., & Shulman, G. I. (2019). The integrative biology of type 2 diabetes. Nature, 576(7785), 51-60.‏

[4] Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001). Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. New England journal of medicine, 345(11), 790-797.‏

[5] Schellenberg, E. S., Dryden, D. M., Vandermeer, B., Ha, C., & Korownyk, C. (2013). Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Annals of internal medicine, 159(8), 543-551.‏

[6] Fuchsberger, C., Flannick, J., Teslovich, T. M., Mahajan, A., Agarwala, V., Gaulton, K. J., ... & Koistinen, H. A. (2016). The genetic architecture of type 2 diabetes. Nature, 536(7614), 41-47.‏

[7] McCarthy, M. I. (2010). Genomics, type 2 diabetes, and obesity. New England Journal of Medicine, 363(24), 2339-2350.‏

[8] Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., ... & Martín, C. (2020). Pathophysiology of type 2 diabetes mellitus. International journal of molecular sciences, 21(17), 6275.‏

[9] Gregorich, M., Kammer, M., Heinzel, A., Böger, C., Eckardt, K. U., Heerspink, H. L., ... & BEAt-DKD Consortium. (2023). Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney Disease. JAMA Network Open, 6(4), e231870-e231870.‏

[10] Deng, Y., Li, N., Wu, Y., Wang, M., Yang, S., Zheng, Y., ... & Gao, J. (2021). Global, regional, and national burden of diabetes-related chronic kidney disease from 1990 to 2019. Frontiers in endocrinology, 12, 672350.‏

[11] Rossing, P., Caramori, M. L., Chan, J. C., Heerspink, H. J., Hurst, C., Khunti, K., ... & Olowu, W. A. (2022). Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int, 102(5S), S1-S127.‏

[12] Care, D. (2022). Addendum. 11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022: Diabetes Care 2022; 45 (Suppl. 1): S175–S184. Diabetes Care.‏

[13] Akbari, M., & Hassan-Zadeh, V. (2018). IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology, 26, 685-698.‏

[14] Nikzad, A., Alizadeh, A., Abediankenari, S., Kashi, Z., & Mahrooz, A. (2023). Paraoxonase 1 activity is associated with interleukin-6 levels in type 2 diabetes: Effects of age and gender. International Journal of Preventive Medicine, 14.‏

[15] Kristiansen, O. P., & Mandrup-Poulsen, T. (2005). Interleukin-6 and diabetes: the good, the bad, or the indifferent?. Diabetes, 54(suppl_2), S114-S124.‏

[16] Huth, C., Illig, T., Herder, C., Gieger, C., Grallert, H., Vollmert, C., ... & Heid, I. M. (2009). Joint analysis of individual participants’ data from 17 studies on the association of the IL6 variant-174G> C with circulating glucose levels, interleukin-6 levels, and body mass index. Annals of medicine, 41(2), 128-138.‏

[17] Mukhopadhyaya, P. N., Acharya, A., Chavan, Y., Purohit, S. S., & Mutha, A. (2010). Metagenomic study of single-nucleotide polymorphism within candidate genes associated with type 2 diabetes in an Indian population. Genet Mol Res, 9(4), 2060-8.‏

[18] Tsalamandris, S., Antonopoulos, A. S., Oikonomou, E., Papamikroulis, G. A., Vogiatzi, G., Papaioannou, S., ... & Tousoulis, D. (2019). The role of inflammation in diabetes: current concepts and future perspectives. European cardiology review, 14(1), 50.‏

[19] wizard genomic DNA purification kit www.promega.com.

[20] Queipo-Ortuno, M. I., Tena, F., Colmenero, J. D., & Morata, P. (2008). Comparison of seven commercial DNA extraction kits for the recovery of Brucella DNA from human serum samples using real-time PCR. European Journal of Clinical Microbiology & Infectious Diseases, 27, 109-114.

[21] Dunbar, B. S. (1987). Two Dimensional Electrophoresis and Immunological Techniques. New York: Plenum Press. And Gersten, D. M. (1996). Gel Electrophoresis (Essential Techniques Series). New York: Wiley. And Kuhr, W. G. (1990). Capillary Electrophoresis. Anal Chem 62:403R–414R.

[22] Illig, T., Bongardt, F., Schopfer, A., Muller-Scholze, S., Rathmann, W., Koenig, W., ... & Kooperative Gesundheitsforschung im Raum Augsburg/Cooperative Research in the Region of Augsburg (KORA). (2004). Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism, 89(10), 5053-5058.‏

[23] Joshi, M., & Deshpande, J. D. (2010). Polymerase chain reaction: methods, principles and application. International Journal of Biomedical Research, 2(1), 81-97.‏

[24] Lee, P. Y., Costumbrado, J., Hsu, C. Y., & Kim, Y. H. (2012). Agarose gel electrophoresis for the separation of DNA fragments. JoVE (Journal of Visualized Experiments), (62), e3923.‏

[25] Berca, L. M., Mosoiu, C. E., Nica, S., APOSTOL, P. P., Nica, R., & Cimponeriu, D. (2021). Study on VDR Polymorphism Influence in Associating with Diabetes Mellitus. ROMANIAN BIOTECHNOLOGICAL LETTERS, 26(1), 2249-2254.‏

[26] Stephens, J. W., Hurel, S. J., Cooper, J. A., Acharya, J., Miller, G. J., & Humphries, S. E. (2004). A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus. Molecular genetics and metabolism, 82(2), 180-186.‏

Verifying The Association Between IL6 -174G/C Polymorphism in Type 2 Diabetes Mellitus. (2024). Journal Port Science Research, 7(1), 36-42. https://doi.org/10.36371/port.2024.1.6

كيفية الاقتباس

Verifying The Association Between IL6 -174G/C Polymorphism in Type 2 Diabetes Mellitus. (2024). Journal Port Science Research, 7(1), 36-42. https://doi.org/10.36371/port.2024.1.6